| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/18/2003 | US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer |
| 09/18/2003 | US20030176330 55562 and 21617, novel human proteins and methods of use thereof |
| 09/18/2003 | US20030176329 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| 09/18/2003 | US20030176328 For producing medicament for therapy of type 1 diabetes; impaired glucose tolerance; type 2 diabetes; syndrome X; obesity; cardiovascular disease, such as atherosclerosis; septic shock; or dyslipidemia rheumatoid arthritis |
| 09/18/2003 | US20030176327 Antibiotics for treating biohazardous bacterial agents |
| 09/18/2003 | US20030176325 Modified peptide nucleic acid (PNA) molecules |
| 09/18/2003 | US20030176324 Derivatives of water insoluble drugs which exhibit good activity and water solubility |
| 09/18/2003 | US20030176323 System for treating kidney disease in diabetic and non-diabetic patients |
| 09/18/2003 | US20030176322 System for treating heart disease and cardiovascular disease in diabetic and non-diabetic patients |
| 09/18/2003 | US20030176321 Capable of increasing glucose oxidation in an affected area and therefore providing more energy for treating wounds, promoting healing |
| 09/18/2003 | US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha |
| 09/18/2003 | US20030176315 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 09/18/2003 | US20030175974 Human gene therapy |
| 09/18/2003 | US20030175962 Gene encoding b protein |
| 09/18/2003 | US20030175960 Isolation, cloning of genes; anticancer agents, autoimmune disease; genetic engineered cells immobilized with hyaluronic acid |
| 09/18/2003 | US20030175958 Methods for using bag expression as a cell differentiation agent and marker |
| 09/18/2003 | US20030175950 RNA interference mediated inhibition of HIV gene expression using short interfering RNA |
| 09/18/2003 | US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents |
| 09/18/2003 | US20030175930 Crystals of LuxP and complexes thereof |
| 09/18/2003 | US20030175929 Recombinant human creatine kinase heterodimer with solution-stability |
| 09/18/2003 | US20030175928 Mitogen-activated protein kinase MEK6 and methods of use therefor |
| 09/18/2003 | US20030175927 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/18/2003 | US20030175924 Human lysophosphatidic acid acyltransferase |
| 09/18/2003 | US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/18/2003 | US20030175919 ITI-D1 Kunitz domain mutants as hNE inhibitors |
| 09/18/2003 | US20030175905 Anticholesterol agents; antilipemic agent; antiinflammatory agents; obesity |
| 09/18/2003 | US20030175898 Isolated nucleic acids; immune response disease |
| 09/18/2003 | US20030175895 Chemokine |
| 09/18/2003 | US20030175894 Chemokine alpha-6 |
| 09/18/2003 | US20030175890 For treatment of auto-immune and immunde disorders and chronic obstructive pulmonary disease; FAIL is an Fc receptor |
| 09/18/2003 | US20030175885 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 09/18/2003 | US20030175884 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 09/18/2003 | US20030175883 DNA encoding a mammalian LPA receptor and uses thereof |
| 09/18/2003 | US20030175881 Nucleic acids encoding (poly) peptides having chips activity |
| 09/18/2003 | US20030175880 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175879 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175878 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175877 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment |
| 09/18/2003 | US20030175875 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175874 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175873 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175872 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175871 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175870 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175869 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175868 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175867 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175866 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175865 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175858 Of given sequence; diagnostic and therapeutic methods useful for treating unspecified diseases, disorders, and/or conditions related to the proteins |
| 09/18/2003 | US20030175857 Of given sequence termed Con-218; constructs and recombinant host cells incorporating the genes; antibodies ; used as therapeutic target and to purify G-proteins |
| 09/18/2003 | US20030175855 Human sdf-5 protein and compositions |
| 09/18/2003 | US20030175849 Identifying compounds for treating vision defects associated with intraocular pressure |
| 09/18/2003 | US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease |
| 09/18/2003 | US20030175837 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 09/18/2003 | US20030175834 Polyphenol inhibition of nucleoside diphosphate kinase-B activity and cancer metastasis |
| 09/18/2003 | US20030175833 Packaged pharmaceuticals and methods for causing compounds and pharmaceutical compositions to be used as inhibitors of neoplastic lesions |
| 09/18/2003 | US20030175830 Reagents and methods for the screening of compounds useful in the treatment of neurological diseases |
| 09/18/2003 | US20030175808 Novel protein and dna thereof |
| 09/18/2003 | US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 09/18/2003 | US20030175801 Treating cancer via increase in expression of interferons and colony stimulating factors with concomitant decrease in transforming growth factor, prostaglandin and vascular endothelial growth factors expression in cells; immunoassays |
| 09/18/2003 | US20030175793 Comprises oligonucleotides for use in gene expression inhibition and treatment of cancer, multiple sclerosis and atherosclerosis |
| 09/18/2003 | US20030175792 Chemokine Alpha-4 |
| 09/18/2003 | US20030175787 Comprises nucleotide sequences coding transport protein for diagnosis and treatment of cell proliferative disorders such as cancer; animal models; antiproliferative agents |
| 09/18/2003 | US20030175778 Interferon Receptor HKAEF92 |
| 09/18/2003 | US20030175772 Microarray of nuclelotide sequences for use in gene expression inhibition; antisense therapy; antitumor agents |
| 09/18/2003 | US20030175766 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 09/18/2003 | US20030175754 Comprises rat ventral prostate protein-1 (RVP-1) for diagnosis and treatment of inflammatory bowel diseases |
| 09/18/2003 | US20030175752 Comprises nucleotide sequences coding apyrase and/or hydrolase (NDPase) activity for treating or preventing thrombosis; thrombolytic agents |
| 09/18/2003 | US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 09/18/2003 | US20030175748 Novel human G-protein coupled receptor, HGPRBMY3, expressed highly in immune- and colon- related tissues |
| 09/18/2003 | US20030175745 Peptides with growth inhibitory action |
| 09/18/2003 | US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening |
| 09/18/2003 | US20030175733 Polypeptides having diagnostic, preventive, therapeutic, and other uses |
| 09/18/2003 | US20030175712 Comprises nucleic acid coding cell division cycle molecule (CDC24); g-protein coupled receptor for treatment and prevention of fungal infections; antitumor agents |
| 09/18/2003 | US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 09/18/2003 | US20030175703 RNA aptamers and methods for identifying the same |
| 09/18/2003 | US20030175685 Using amino acid sequences to control apoptosis and prevent or treat cancer and viral infections |
| 09/18/2003 | US20030175681 Inhibition of CMV infection and dissemination |
| 09/18/2003 | US20030175680 Methods of treating and preventing bone loss |
| 09/18/2003 | US20030175359 Egg treated to add 4.2 ppm or more iodine |
| 09/18/2003 | US20030175352 Having a plurality of solid, polymeric matrix beads comprising considerable amounts of greasy/oily/sticky substances and having fast release characteristics; drug delivery |
| 09/18/2003 | US20030175351 Pharmaceutical composition for oral use with improved absorption |
| 09/18/2003 | US20030175350 Containing thyrotropin-releasing hormone or derivatives thereof as medicinally active ingredient; excellent in absorbability |
| 09/18/2003 | US20030175344 Comprising diuretic, beta blocker, angiotensin converting enzyme inhibitor, angiotensin II receptor antagonist, calcium channel blocker, lipid-regulating agent, platelet function altering agent, serum homocysteine lowering agent |
| 09/18/2003 | US20030175313 Preparation of sterile stabilized nanodispersions |
| 09/18/2003 | US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine |
| 09/18/2003 | US20030175293 Choline binding proteins for anti-pneumococcal vaccines |
| 09/18/2003 | US20030175290 Molecular antigen array |
| 09/18/2003 | US20030175289 TIE ligands |
| 09/18/2003 | US20030175286 Use of mosquito salivary tachykinins to remediate unregulated cellular proliferation |
| 09/18/2003 | US20030175285 Major histocompatibility complex ligands, comprising proteins, peptides, epitopes, polypeptides, mimetics or lipopeptides, used as vaccines |
| 09/18/2003 | US20030175282 Photodynamic therapy comprising administering angiogenesis factor antagonists and photosensitizers then irradiating with lasers, for prophylaxis of vision defects |
| 09/18/2003 | US20030175281 Monoclonal antibodies that preferntially bind to proteins having cytolysis and immunogenic activity |
| 09/18/2003 | US20030175280 Antagonists to chaperonin 10 |
| 09/18/2003 | US20030175279 Diagnosing and prophylaxis of tumors, endometriosis and fibroids, by administering Endometrial Steroid Binding Protein II (ESBPII) antagonists, then analyzing the polypeptide concentration in cells, tissues or fluids |
| 09/18/2003 | US20030175277 Administering mixtures of antigens and phospholipase inhibitors as antitumor or anticarcinogenic agents |
| 09/18/2003 | US20030175275 Methods of treatment by multiple administration of chimeric anti-TNF antibodies |
| 09/18/2003 | US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |